[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BiotechCH Biotech Hangout Biotech Hangout posts on X about $xbi, $mplt, $azn, $akro the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1353752829266194434/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +9.10% - X Months XXXXXXX -XX% - X Year XXXXXXX -XXXX% ### Mentions: X [#](/creator/twitter::1353752829266194434/posts_active)  - X Week X -XX% - X Month XX +3.70% - X Months XXX -XX% - X Year XXX -XXXX% ### Followers: XXXXXX [#](/creator/twitter::1353752829266194434/followers)  - X Week XXXXXX +0.29% - X Month XXXXXX +1.40% - X Months XXXXXX +8.90% - X Year XXXXXX +18% ### CreatorRank: XXXXXXX [#](/creator/twitter::1353752829266194434/influencer_rank)  ### Social Influence [#](/creator/twitter::1353752829266194434/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% [currencies](/list/currencies) XXX% [exchanges](/list/exchanges) XXXX% [social networks](/list/social-networks) XXXX% [technology brands](/list/technology-brands) XXXX% **Social topic influence** [$xbi](/topic/$xbi) #6, [$mplt](/topic/$mplt) #1, [$azn](/topic/$azn) 1.9%, [$akro](/topic/$akro) 0.95%, [$novo](/topic/$novo) 0.95%, [$bmyorbital](/topic/$bmyorbital) 0.95%, [ipo](/topic/ipo) 0.95%, [$aznalgen](/topic/$aznalgen) 0.95%, [$snybenchsci](/topic/$snybenchsci) 0.95%, [$101m](/topic/$101m) XXXX% **Top accounts mentioned or mentioned by** [@samfazeli8](/creator/undefined) [@ericschmidt151](/creator/undefined) [@bradloncar](/creator/undefined) [@matteispaul](/creator/undefined) [@tlorriman](/creator/undefined) [@biotech1](/creator/undefined) [@timopler](/creator/undefined) [@daphnezohar](/creator/undefined) [@cngarabedian](/creator/undefined) [@yaireinhorn](/creator/undefined) [@yaronwerber](/creator/undefined) [@mbrushstocks](/creator/undefined) [@jmaraganore](/creator/undefined) [@nkjellson](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@bioinvestor24](/creator/undefined) [@artsstocks](/creator/undefined) [@thenorthstar5](/creator/undefined) [@gline](/creator/undefined) [@brianskorney](/creator/undefined) **Top assets mentioned** [Bitcoin Incognito (XBI)](/topic/$xbi) [AstraZeneca PLC (AZN)](/topic/$azn) [Akropolis (AKRO)](/topic/$akro) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) ### Top Social Posts [#](/creator/twitter::1353752829266194434/posts) --- Top posts by engagements in the last XX hours "On todays #BiotechHangout @t_lorriman @BrianSkorney @SamFazeli8 @YaronWerber & @luba_greenwood will cover deals & financings: $AKRO/$NOVO #MASH deal $BMY/Orbital deal MapLight ($MPLT) IPO AI Pharma deals: $AZN/Algen $SNY/BenchSci Nilo Therapeutics $101M Series A Ascentas $325M first biotech fund company news: $RCUS #ccRCC data $SKYE CBeyond Phase 2a data $DYN DM1 data & #WMS2025 DMD presentations $IONS Innovation Day regulatory: $LXEO FDA update Peter Marks joins $LLY plus board evolution & effective vs. ineffective boards much more:" [X Link](https://x.com/BiotechCH/status/1976642657410552132) [@BiotechCH](/creator/x/BiotechCH) 2025-10-10T13:35Z 15.1K followers, 5853 engagements ".@soowannaway (Graig Suvannavejh) is optimistic about the recent surge noting the $XBIs XX% + rally off the lows triggered by earlier tariff announcements: In the past month or so it feels very tangible.Macro things with uncertainty earlier in year with respect to Washington D.C policies RFK Jr. and what he may have brought forth changes in FDA and noise around potential lowering of prices. Today its not as bad as people think. Theres still uncertainty every day of what might come out of Washington D.C. but from an investor perspective worse case fears havent materialized.How sustainable this" [X Link](https://x.com/BiotechCH/status/1979220628231327875) [@BiotechCH](/creator/x/BiotechCH) 2025-10-17T16:19Z 15.1K followers, XXX engagements "On todays #BiotechHangout @MatteisPaul @SamFazeli8 @JMaraganore @soowannaway (Graig Suvannaveijh) discuss the $XBI & sector performance drivers $SNYs X% stock dip despite Ph3 eczema success $INSMs incredible year & readthrough from $UTHRs Ph3 IPF data Corsera Health $50M launch #ESC2025: $IONS & $ARWR ApoC3 data ASO vs RNAi discussion tracking upcoming data: big year for AD readouts plus QUREs AMT-130 $HRMYs ZYN00 #WCLC25: $SMMTs ivonescimab & $AZNs FLAURA2 $AXSM AXS-05/Auvelity expected sNDA submission plus discussion themes: obesity readouts - is obesity a zero sum game biomarkers - do" [X Link](https://x.com/BiotechCH/status/1963950153967993086) [@BiotechCH](/creator/x/BiotechCH) 2025-09-05T12:59Z 15.1K followers, 5280 engagements "On todays #BiotechHangout @MatteisPaul @JMaraganore @EricSchmidt151 & @soowannaway (Graig Suvannaveijh) will discuss market sentiment strong $XBI & whether were ready for biotech IPOs plus the latest on policy: FDA Commissioners National Priority Voucher (CNPV) recipients White House GLP-1 pricing comments plus HAE consolidation: $BCRX/$ATXS $700M deal regulatory: $LEGN label update & Q3 Carvykti sales FDAs OAI letter to $NVO mfg facility & impact on $SKKR & $REGN $BCAX BTD for head & neck cancer @statnews Summit takeaways company news: $REGN/Decibel hearing loss data $XNCR leaked abstracts" [X Link](https://x.com/BiotechCH/status/1979181209079939554) [@BiotechCH](/creator/x/BiotechCH) 2025-10-17T13:42Z 15.1K followers, 4800 engagements "President Trump says Ozempic (GLP-1) prices will drop from $1300 to $XXX but this was walked back by Dr. Oz who clarified the number wasnt official and prices may land higher. My guess is if these pharma companies with all their sophistication and financial planning and analysis powers are cutting a deal with the government it's probably going to be an okay deal economically for them. Of course a lot has been made of the fact that Pfizer hasnt had to restate guidance or refile any SEC paperwork any changes to its financial condition in the wake of its deal with the White House.I think we can" [X Link](https://x.com/BiotechCH/status/1979227064566788275) [@BiotechCH](/creator/x/BiotechCH) 2025-10-17T16:44Z 15.1K followers, XXX engagements "Why did $AZN choose Algen @luba_greenwood explains: Algens technology provides AI and also combines functional genomics CRISPR screening and CRISPR modulation. It maps out a causal link between gene regulation and disease progression in human cell types They're using high throughput screening AI models all to figure out which genes are therapeutically actionable and which ones are not. So it will help a company like $AZN with translation from human biology and our understanding into immunology and finding novel targets around which they'll have exclusive rights I think it's a great deal and" [X Link](https://x.com/BiotechCH/status/1976692077305250081) [@BiotechCH](/creator/x/BiotechCH) 2025-10-10T16:51Z 15.1K followers, XXX engagements "There have been X IPOs this year. Almost all of those were IPOs that happened in January or very early February and then there was nothing says @t_lorriman. Then there was $LBRX and now we've seen $MPLT. $MPLT is a company that is looking to improve Cobenfy which was the drug that Karuna developed that was acquired by $BMY and is currently being launched. This is another great example of biotechs kind of leading the way and showing Big Pharma where there is a lot of opportunity. #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1976690579607073121) [@BiotechCH](/creator/x/BiotechCH) 2025-10-10T16:45Z 15.1K followers, XXX engagements "On todays #BiotechHangout @EricSchmidt151 @SamFazeli8 @BrianSkorney & @YaronWerber cover the latest macro news: TrumpRx MFN pricing/tariffs $PFE/White House deal $AZN moving to NYSE $XBI broke XXX are we in a biotech bull market George Tidmarshs LinkedIn posts FDA derails $IOBTs cancer vaccine plan $APLTs stock volatility company news: $GMAB/$MRUS deal & impact for $BCAX $MLTX #HidradenitisSuppurativa data $LRMR #FriedreichsAtaxia data & stock fall $ENTA RSV data & big stock reversal Q4 conferences: #ESMO2025 preview Q4 earnings season plus $GSK CEO change & more:" [X Link](https://x.com/BiotechCH/status/1974097465763619270) [@BiotechCH](/creator/x/BiotechCH) 2025-10-03T13:01Z 15.1K followers, 7932 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiotechCH Biotech Hangout
Biotech Hangout posts on X about $xbi, $mplt, $azn, $akro the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX -XX%
- X Month XXXXXX +9.10%
- X Months XXXXXXX -XX%
- X Year XXXXXXX -XXXX%
Mentions: X #
- X Week X -XX%
- X Month XX +3.70%
- X Months XXX -XX%
- X Year XXX -XXXX%
Followers: XXXXXX #
- X Week XXXXXX +0.29%
- X Month XXXXXX +1.40%
- X Months XXXXXX +8.90%
- X Year XXXXXX +18%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXXX% finance XXXX% currencies XXX% exchanges XXXX% social networks XXXX% technology brands XXXX%
Social topic influence $xbi #6, $mplt #1, $azn 1.9%, $akro 0.95%, $novo 0.95%, $bmyorbital 0.95%, ipo 0.95%, $aznalgen 0.95%, $snybenchsci 0.95%, $101m XXXX%
Top accounts mentioned or mentioned by @samfazeli8 @ericschmidt151 @bradloncar @matteispaul @tlorriman @biotech1 @timopler @daphnezohar @cngarabedian @yaireinhorn @yaronwerber @mbrushstocks @jmaraganore @nkjellson @adamfeuerstein @bioinvestor24 @artsstocks @thenorthstar5 @gline @brianskorney
Top assets mentioned Bitcoin Incognito (XBI) AstraZeneca PLC (AZN) Akropolis (AKRO) Dyne Therapeutics, Inc. Common Stock (DYN) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Arrowhead Research Corporation (ARWR) Bristol-Myers Squibb Co (BMY) Merus N.V. Common Shares (MRUS) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
Top Social Posts #
Top posts by engagements in the last XX hours
"On todays #BiotechHangout @t_lorriman @BrianSkorney @SamFazeli8 @YaronWerber & @luba_greenwood will cover deals & financings: $AKRO/$NOVO #MASH deal $BMY/Orbital deal MapLight ($MPLT) IPO AI Pharma deals: $AZN/Algen $SNY/BenchSci Nilo Therapeutics $101M Series A Ascentas $325M first biotech fund company news: $RCUS #ccRCC data $SKYE CBeyond Phase 2a data $DYN DM1 data & #WMS2025 DMD presentations $IONS Innovation Day regulatory: $LXEO FDA update Peter Marks joins $LLY plus board evolution & effective vs. ineffective boards much more:"
X Link @BiotechCH 2025-10-10T13:35Z 15.1K followers, 5853 engagements
".@soowannaway (Graig Suvannavejh) is optimistic about the recent surge noting the $XBIs XX% + rally off the lows triggered by earlier tariff announcements: In the past month or so it feels very tangible.Macro things with uncertainty earlier in year with respect to Washington D.C policies RFK Jr. and what he may have brought forth changes in FDA and noise around potential lowering of prices. Today its not as bad as people think. Theres still uncertainty every day of what might come out of Washington D.C. but from an investor perspective worse case fears havent materialized.How sustainable this"
X Link @BiotechCH 2025-10-17T16:19Z 15.1K followers, XXX engagements
"On todays #BiotechHangout @MatteisPaul @SamFazeli8 @JMaraganore @soowannaway (Graig Suvannaveijh) discuss the $XBI & sector performance drivers $SNYs X% stock dip despite Ph3 eczema success $INSMs incredible year & readthrough from $UTHRs Ph3 IPF data Corsera Health $50M launch #ESC2025: $IONS & $ARWR ApoC3 data ASO vs RNAi discussion tracking upcoming data: big year for AD readouts plus QUREs AMT-130 $HRMYs ZYN00 #WCLC25: $SMMTs ivonescimab & $AZNs FLAURA2 $AXSM AXS-05/Auvelity expected sNDA submission plus discussion themes: obesity readouts - is obesity a zero sum game biomarkers - do"
X Link @BiotechCH 2025-09-05T12:59Z 15.1K followers, 5280 engagements
"On todays #BiotechHangout @MatteisPaul @JMaraganore @EricSchmidt151 & @soowannaway (Graig Suvannaveijh) will discuss market sentiment strong $XBI & whether were ready for biotech IPOs plus the latest on policy: FDA Commissioners National Priority Voucher (CNPV) recipients White House GLP-1 pricing comments plus HAE consolidation: $BCRX/$ATXS $700M deal regulatory: $LEGN label update & Q3 Carvykti sales FDAs OAI letter to $NVO mfg facility & impact on $SKKR & $REGN $BCAX BTD for head & neck cancer @statnews Summit takeaways company news: $REGN/Decibel hearing loss data $XNCR leaked abstracts"
X Link @BiotechCH 2025-10-17T13:42Z 15.1K followers, 4800 engagements
"President Trump says Ozempic (GLP-1) prices will drop from $1300 to $XXX but this was walked back by Dr. Oz who clarified the number wasnt official and prices may land higher. My guess is if these pharma companies with all their sophistication and financial planning and analysis powers are cutting a deal with the government it's probably going to be an okay deal economically for them. Of course a lot has been made of the fact that Pfizer hasnt had to restate guidance or refile any SEC paperwork any changes to its financial condition in the wake of its deal with the White House.I think we can"
X Link @BiotechCH 2025-10-17T16:44Z 15.1K followers, XXX engagements
"Why did $AZN choose Algen @luba_greenwood explains: Algens technology provides AI and also combines functional genomics CRISPR screening and CRISPR modulation. It maps out a causal link between gene regulation and disease progression in human cell types They're using high throughput screening AI models all to figure out which genes are therapeutically actionable and which ones are not. So it will help a company like $AZN with translation from human biology and our understanding into immunology and finding novel targets around which they'll have exclusive rights I think it's a great deal and"
X Link @BiotechCH 2025-10-10T16:51Z 15.1K followers, XXX engagements
"There have been X IPOs this year. Almost all of those were IPOs that happened in January or very early February and then there was nothing says @t_lorriman. Then there was $LBRX and now we've seen $MPLT. $MPLT is a company that is looking to improve Cobenfy which was the drug that Karuna developed that was acquired by $BMY and is currently being launched. This is another great example of biotechs kind of leading the way and showing Big Pharma where there is a lot of opportunity. #BiotechHangout"
X Link @BiotechCH 2025-10-10T16:45Z 15.1K followers, XXX engagements
"On todays #BiotechHangout @EricSchmidt151 @SamFazeli8 @BrianSkorney & @YaronWerber cover the latest macro news: TrumpRx MFN pricing/tariffs $PFE/White House deal $AZN moving to NYSE $XBI broke XXX are we in a biotech bull market George Tidmarshs LinkedIn posts FDA derails $IOBTs cancer vaccine plan $APLTs stock volatility company news: $GMAB/$MRUS deal & impact for $BCAX $MLTX #HidradenitisSuppurativa data $LRMR #FriedreichsAtaxia data & stock fall $ENTA RSV data & big stock reversal Q4 conferences: #ESMO2025 preview Q4 earnings season plus $GSK CEO change & more:"
X Link @BiotechCH 2025-10-03T13:01Z 15.1K followers, 7932 engagements